Document dQ75r83BEGNGZBzMVLvmRzQ1B
ur
ATTORNEYS IT LAW
RECEIVED OUDEC !0 PH 2: 03
December 10, 2004
AR2S&- f i
2550 M Street, NW Washington, DC 20037-1350 202-457-6000
Facsimile 202-457-6315 www.pattonboggs.com
Peter D. Robertson (202) 457-0320 probertson@pattonboggs.com
Mr. Charles M. Auer
Director
Office o f Pollution Prevention and Toxics
U.S. Environmental Protection Agency
EPA East
89050000112/S
1201 Constitution Avenue, NW
Washington, DC 20460
0 1
Re: Further Dupont Voluntary Response to EPA's November 4, 2004 Request Submission to AR 226 and TSCA 8(e) Office Blood Monitoring Information
Dear Charlie:
The attached document production and information submitted with this letter represents DuPont's continued good faith effort to respond to EPA's November 4, 2004 request for voluntary submission o f certain material.
Submission for December 10, 2004
The documents submitted with this letter pertain to the submission requested by December 10, 2004. Specifically, this submission pertains to occupational blood monitoring summary documents and/or reports. A summary o f the steps taken to collect the information requested by EPA for this submission, along with the guidelines used to assess responsiveness to the EPA request, is provided on the Attachment 1 to this letter.
A summary o f the contents o f this submission is provided in Attachment 2 to this letter. There is a public version o f the submission and a CBI version o f the submission. In addition to a cumulative index for this submission, each individual binder also contains an index for the contents o f the binder.
TSCA 8(e) Office Submission
DuPont does not believe that the information submitted with this letter triggers reporting obligations under TSCA section 8(e). However, in the course o f discussions with OPPT and the
- - -j
> -> '
v-'L ;
W a s h i n g t o n DC
| Northern Virginia
| Dallas
| Denver
| Anchorage
| Doha, Qatar
OOOOOl
Y A l . W 1S 0M
P-2
- PATTON BOGGS.
, M l l l l E t S II LAW
Mr. Charles M. Auer December 10, 2004 Page 2
Office o f Regulatory Enforcement (ORE), it has become clear to DuPont that those two offices are applying standards o f reporting under TSCA section 8(e) that DuPont cannot anticipate. Accordingly, DuPont initially informed EPA that DuPont intended to submit this production to both the AR-226 docket and the TSCA 8(e) office, as was done with the submission of November 15, 2004. EPA has, however, informed counsel for DuPont that it is not necessary to make a duplicate, formal submission to the 8(e) office in order to discharge any reporting obligations that EPA might otherwise assert. Instead, EPA has asked that DuPont make only a single submission and advised that DuPont should indicate in this cover letter that the submission is intended for both the AR-226 docket and the TSCA 8(e) office.
As such, DuPont states that the enclosed documents are intended to be a submission to both the AR-226 docket and, as a precaution, to the TSCA 8(e) office, notwithstanding DuPont's firm belief that the information does not trigger reporting obligations under that section o f TSCA. This submission should not be construed as a direct or indirect admission that DuPont believes that any o f the enclosed information triggers such reporting obligations. We understand that O R E has agreed that DuPont's submission shall not prevent DuPont from asserting, in any proceeding, that section 8(e) did not require submission o f this information.
Continued Activity
After EPA has had the opportunity to review this letter and the documents, we are available at your convenience to discuss the documents in further detail to assist in your understanding. In the meantime, we will continue to gather materials for the remaining submissions, review and produce any additional documents that are located and are relevant to the topics that are the subject o f this submission, and create the electronic files you requested.
Please contact me direcdy if you have any questions or need further clarification with respect to this submission.
Si
Pi ertson
Attachments Attachment 1 Attachment 2 --Summary o f submission Public submission --number o f boxes: 1 CBI submission -- number of boxes: 1
000002
p .3
PATTON BOGGS. i t i i i m s ii u
Mr. Charles M. Auer December 10, 2004 Page 3
ATTACHMENT 1
The sections below provide a summary o f the steps taken to collect and produce the information requested in the particular category indicated. For each category, please note that DuPont does not maintain a comprehensive file o f all such information for the entire Company. The documents were collected either from the over one million pages o f documents collected for a class action lawsuit in West Virginia or from files o f individuals most likely to have documents responsive to EPA 's request. Note that the documents collected for purposes o f the West Virginia litigation are primarily related to PFOA.
For purposes o f this document production, and in the interest o f attempting to make this production useful and purposeful to the Agency and to avoid redundancy, DuPont followed the guidelines provided below. Please note, however, that if the Agency wants DuPont to submit the type o f information that is indicated below as not being submitted herewith, please notify us and we will provide the requested information.
General Guidelines for December 10 Submission
This submission does not include the following types o f documents:
Draft documents where it is known that a final version exists Documents known to be in the possession o f EPA (either at headquarters or an EPA
Regional Office) Non-DuPont documents (includes documents from other companies, plaintiffs' counsel, etc.) Presentations and other documents that reference data that is in a report submitted to EPA Documents that are subject to attorney-client privilege Documents concerning work-in-progress (Note though that DuPont will provide periodic
updates to EPA on work-in-progress, per the November 10, 2004 presentation to EPA, and will submit reports on such work to EPA when final) Supporting reports (e.g., lab analysis, etc.) for blood monitoring results
Summary of Collection Process for Specific Categories of Requested Information
The documents for this submission were collected from review o f the documents produced in the class action litigation, along with collection o f documents from individuals in the Company most likely to possess such information.
000003
P-4
- PATTON B06G L mums u uw Mr. Charles M. Auer December 10, 2004 Page 4
In addition, to aid in understanding the information submitted, DuPont summarized the blood data from Washington Works, Fayetteville, and Chambers Works. These summaries are found in Volume 35 as follows: Tab 28 Chambers Works (non-telomer) Tab 77 Chambers Works (telomers) Tab 34 Fayetteville Tab 64 Washington Works Finally, Volume 36 is a printout o f the Fluoropolymers Laboratory Analysis Information Retrieval (FLAIR) database as from the Washington Works facility. Each page contains the work history and blood monitoring results for an individual employee (the name o f the employee has been redacted from each page for privacy purposes). Note that the FLAIR database contains monitoring data through 2.003; it does not yet contain the monitoring data collected for 2004. Year 2004 data for Washington Works is provided in Volume 35, Tab 64.
000004
> PATTON BOGGS.. n i m m U UK
Mr. Charles M. Auer December 10, 2004 Page 5
ATTACHMENT 2
Summary o f Decem ber 10,2004 Subm ission
Public Version
Box no.
1 1 1
Volume
_ 35 36
Part no.
_ -
Topic
Cumulative index Blood Monitoring Fluoropolymers Laboratory Analysis Information Retrieval (FLAIR) database
Confidential Version
Box no.
1 1 1
Volume
. 35 36
Part no. _
-
Topic
Cumulative index Blood Monitoring Fluoropolymers Laboratory Analysis Information Retrieval (FLAIR) database [note that this binder does not contain TSCA CBI, but employee names have been redacted for privacy purposes
000005
Blood Monitoring
Volume 35
December 10,2004 EPA PRODUCTION
Company Sanitized - Does Not Contain TSCA CBI
000006
j INDEX j NUMBER
DATE
10 3 5 - 0 0 1 ...T 9 8 1 0 9
j......
TITLE/ D ESCRIPTIO N
|Blood - D e te rm in a tio n of {Perfluorooctanoic Acid, Gas ;C h ro m a to g ra p h ic M ethod
REPORT NUMBER
jB 4 65.50 00
|0 3 5 -0 0 1
119811109
Blood - D eterm in ation of IB 4 6 5 .5 0 0 0 Perfluorooctanoic Acid, Gas Chrom atographic Method
j SUBJECT MATERIA { P e rflu o ro o cta n o ic Acic
j C -8
10 3 5 -0 0 2 11 9 9 8 0 7 1 6 IA n a ly s is o f C -8 in blood,
\iiH2
j035-003
jstatu s of interlab com parison 20010129 Trip Report Review ing
1 W N ation al M edical S e rv ic e s .....................[M etho d Q 35-Q04 2 0 0 1 1 1 0 9 N a tio n a l M e d ica l S e rv ic e s
\3if0o
j(G C -EC D ) PFOA Method Change Proposal
jno further {inform ation : id e n tifie d {no fu rth er {inform ation [id e n tifie d {no fu rth e r {inform ation {identified
{C-8 {Perfluorooctanoic A ck jP FO A
10 3 5 -0 0 5 1 2 0 0 11122 jD ra ft E u ro p e a n G C / M S
I lfO l
M etho d
10 3 5 - 0 0 6 '' {2 0 0 2 0 1 2 9 Trip R e p o rt R e v ie w in g
! jNational M edical Services .....................[M e tho d , I035-0 7 "" 2 0 0 2 0 6 0 4 jA d v io n S ite M an u a l for
I i+O {Sam ple P rep aration and .....................iSubm jssjon^ (O3 5-008" 2 0 0 2 0 7 1 2 jA d v io n M eth o d V a lid a tio n
Report: Method Validation jfor the Q uantitation of
no further [inform ation
{Perfluorooctanoic Acic
{identified
j
jno further {inform ation
Perfluorooctanoic Ada
]id e n tifie d
j D PO N T S M .D O C .... p f ..............................
j0 2 120V D JA _D U .D {Am m onium jO C jPerfluorooctanoate
{Am m onium
jPerfluorooctanoate Anion
|(PFOA, 0.05 to 10
jm icrogram s/m illiliter
{C o n c e n tra tio n R a n g e ), in
{Human Serum by Turbo Ion
jSpray LC/MS/MS
TRADENAME or CODE
no further nform ation d e n tifie d
\C A S R E G IS T R Y j D O C U M E N T
NUMBER
TYPE
{335-67-1
{Method
no further nform ation id e n tifie d
13825-26-1
TM {Method
no further inform ation id e n tifie d no further nform ation d e n tifie d
0 further nform ation dentified
j3825-26-1
{Method
.{.......................... {335-67-1
:..
{Report
.1.............................
j3 3 5 -6 7 -l
Report
no further inform ation id e n tifie d no further inform ation
le n tifie d no further nform ation
entified 0 further nform ation e n tifie d
[335-67-1
M eth od
i...............................
j3 3 5 -6 7 -l
Report
{......................... 1335-67-1
Manual
l................................
{3825-26-1
Report
[ EPA DOCKET i |
"B a te s" NUMBER
jno further 'in form atio n id e n tifie d
{no further j inform ation jid e n tifie d
no further inform ation id e n tifie d
ino further {inform ation jid e n tifie d
no further inform ation id e n tifie d no further inform ation id e n tifie d no further inform ation id e n tifie d
jno further {inform ation id e n tifie d {no further j inform ation {identified {no fu rth e r {inform ation {identified
no further inform ation id e n tifie d no further inform ation id e n tifie d no further inform ation dentified no further nform ation d e n tifie d
{no further inform ation id e n tifie d no further inform ation id e n tifie d no further inform ation id e n tifie d no further inform ation id e n tifie d
j SITE
CATEGORY .
{no fu rth e r {inform ation jid e n tifie d
{ A n a ly tica l {Methods - PFOA jin Blood
Ino further {inform ation jid e n tifie d
{ A n a ly tica l jMethods - PFOA jin Blood
{Dordrecht W orks
Ino further {inform ation {identified {no fu rth e r {inform ation {identified
{ A n a ly tica l {Methods - PFOA {in B lood { A n a ly tica l {Methods - PFOA {in B lood { A n a ly tica l iM ethods - PFOA jin Blood
Ino further {inform ation {identified jno further {inform ation {identified Ino further j inform ation {identified {no fu rth e r {inform ation {identified
!A n a ly tic a l {Methods - PFOA {in B lo od { A n a ly tica l {Methods - PFOA
! 1 I
{
{ A n a ly tica l jMethods - PFOA {in B lood { A n a ly tica l {Methods - PFOA !in Blood
1
{ {
j035-008 {20020712
lf\
jAdvion Method Validation {Report: M ethod Validation jfor the Q uantitation of
0 2 1 20V D JA _D U .D {Perfluorooctanoate O C {Anion
{Am m onium
f
jPerfluorooctanoate Anion
j(PFOA, 0.05 to 10
{m icrogram s/m illiliter
{ C o nce ntra tio n R a n g e ), in
Human Serum by Turbo Ion i
Spray LC/MS/MS
no further form ation e n tifie d
* w
335-67-1
{Report
no further inform ation id e n tifie d
jno further {inform ation jid e n tifie d
{no fu rth e r {inform ation {identified
;./
Com pany Sanitized - Contains No TSCA CBI
Mj
C O M P A N Y SANITIZEDVolum e 35 Blood Monitori
000007
{ A n a ly tic a l................i {Methods - PFOA i jin Blood
Page 1 of 8
I j! IN D E X !
NUMBER
DATE
T IT LE /D E SC R IR T Z O N
10 3 5 - 0 0 9 ... 12 0 0 3 0 1 3 1 jA d v io n : B io a n a ly tic a l jM ethod Validation for the [Q uantitation of [P e rflu o ro o cta n o ic A cid in
i,.............
I 3 5 - 0 1 0 .... 2 0 0 3 0 9 3 0 jA d vion : Q u a n tita tiv e [D eterm ination of [Am m onium jPerfluorooctanoate (APFO), [Measured as the jPerfluorooctanoate Anion [(PFO A), in H um an S erum [from Stu d y DW 04 Using [Turbo Ion Spray LC/M S/M S
REPORT NUMBER
[no further [inform ation :id e n tifie d
j SUBJECT MATERIAL j TRADENAME or
........C..O.D..E.......
[Perfluorooctanoic Acid no further inform ation id e n tifie d
j CAS REGISTRY NUMBER
[335-67-1
DOCUMENT TYPE
Abstract
02331A D JA DU.D Am m onium OC [Perfluorooctanoate
no further inform ation id e n tifie d
'[3 8 2 5 -2 6 - 1 ............. R e p o rt
EPA DOCKET
"B a te s" NUMBER
no further inform ation id e n tifie d
no further inform ation id e n tifie d
no further inform ation id e n tifie d
no further inform ation identified
SITE
[no further [inform ation [identified
no further inform ation identified
10 3 5 -0 1 0
13 ifoC
20030930 jAdvion: Q uantitative [D eterm ination of [Am m onium [Perfluorooctanoate (APFO), [Measured as the [Perfluorooctanoate Anion [(PFO A), in H um an S erum [from Stu d y DW 04 Using [Turbo Ion Spray LC/M S/M S
:02331AD JA_D U .D [Perfluorooctanoate O C jAnion
no further inform ation identified
:335-67-l
[Report
[no further [inform ation [id e n tifie d
[no further [inform ation [identified
[no further [inform ation [id e n tifie d
[0 3 5 -0 1 1 [2 0 0 4 0 1 0 8 [E xy g e n : M eth o d o f
[Ex M ^ 6 8 -2 7 6
[Analyisis for the
[Revision 2
[D eterm ination of
[34C7
[Perfluorooctanoic Acid [(P FO A ) in S e ru m by
..................... L C / M S / M S R e v is io n 2
]
[ 3 5 -0 1 2 u n d a te d [V a lid a tio n o f D e te rm in a tio n ! no fu rth e r
I3U-09
jof Total Fluo rin e in Blood by [in form ation jW ickbold Torch W ith D irect [identified [Potentiom etric D etection j
[Perfluorooctanoic Acid [no further [inform ation [id e n tifie d
F lu o rin e
..... [no fu rth e r""' [inform ation [identified
335-67-1
[ M eth od
7782-41-4
[Method
[no further [inform ation [ id e n tifie d
[no further [inform ation id e n tifie d
[no further [inform ation [identified
[no further [inform ation [id e n tifie d
jno further [inform ation [identified
jno further [inform ation id e n tifie d
[0 3 5 - 0 1 3 ... [ 9 7 9 0 7 2 3
I H oCi\
[Memo from B. C. M c K u s ic k n o further'"'
[to F .E. F re n ch , Jr., e n title d : [in fo rm a tio n
"D iscussion of
[ id e n tifie d
Fluorochem icals w ith 3M "
Perfluorooctanoic Acid [FC -4 3
[3825-26-1
Mem orandum
no further inform ation id e n tifie d
no further inform ation identified
[no further [inform ation [id e n tifie d
CATEGORY . \
[A n a ly tic a l [Methods - PFOA [in Blood
j
[A n a ly tic a l [Methods - PFOA jin Blood
I
[A n a ly tic a l [Methods - PFOA [in Blood
[A n a ly tic a l [Methods - PFOA [in Blood
j [
[A n a ly tic a l [Methods - PFOA [in Blood
[
G e n e ra l PFOA in [
Blood Data
[
035-Q14 S ;,//>
11 9 7 9 0 7 2 5
i j
IM em o from j / w . Raines to ;R. L. R ichards, entitled : ["O rganic Fluorocom pounds [in Blood"
in o f u r t h e r ....... [inform ation 1id e n tifie d
F lu o rin e [
jno further [inform ation [id e n tifie d
'"['7 7 8 2 -4 1 -4 ......
[M em oran du m
no further [inform ation [ id e n tifie d
035-014
3 LLjQ
119790725
\
iM e m o from J. W. R a in e s t o ' In o f u r t h e r ........
|R. L. R ichards, e ntitled:
iinform ation
["O rganic Fluorocom pounds [identified iin Blood"
[Am m onium Salt of
[ F C - 4 3 ................ ..... [ 3 8 2 5 - 2 6 - .......
[Perfluorooctanoic Acid j
[M em oran du m
[no further [inform ation [id e n tifie d
[no further [inform ation [identified
[no further [inform ation [identified
jC ham bers W orks, [G e n e ra i PFO A'in jW ashington W orks jBlood Data
j C h a m b e rs W o rk s, IG e n e ra l PFO A in :W ashington W orks !Blood Data
Com pany Sanitized - Contains No TSCA CBI
Volum e 35 Blood M onitoring
000008
Page 2 of 8
INDEX ; NUMBER I DATE
T IT LE /D E S C R IP T IO N
REPORT NUMBER
j jS U B JE C T M A T E R I A L ! TR AD EIN A M E o r C A S R E G IS T R Y D O C U M E N T
I CODE
NUMBER
TYPE
[0 3 5 -0 1 5
!1 9 7 9 1 0 1 8 [Table: C '8 f F C - 1 4 3 j " .......... in o fu rth e r
[Am m onium
jinform ation
jAm m onium [P e rflu o ro o c ta n o a te
T C -1 4 3
13825-26-1
[Table
[P e rflu o ro o c ta n o a te
:id e n tifie d
Chronological S u m m ary of
I[..................... ..................iR9.!$s
;035_~Q1 ;
1 9 8 0 0 2 2 8 [Table: F81F [143 Data February, 1980
in o fu rDthe pe ra rtm e n t FC[-A m m o n iu m
iinform ation
IP e rflu o ro o c ta n o a te
F C - 1 4 3 ............... ........[ 3 8 2 5 -2 6 -1 ....... [Table
H-UI
iid e n tifie d
|I
! EPA DOCKET j
"B a te s" NUMBER
ino further [inform ation [identified
Ino further Iinform ation [id e n tifie d
[no further [inform ation [identified
no further inform ation id e n tifie d
jQ35-017
3if)3
;19800303
[Table: S u m m a ry O rganic ;Fluorides in Blood S a m p le s
jno further inform ation [ id e n tifie d
I
[O rganic Fluorides
no further inform ation id e n tifie d
[no further [inform ation [identified
.... jT a b ie ..........
ino further [inform ation [identified
no further inform ation identified
SITE
[| CATEGORY . j
C h a m b e rs W orks, G e n e ra l PFOA in I W ashington W orks Blood Data
Fairfield, M arshall Lab, Philadelphia PE, Philadelphia Plant, Toledo
G e n e ra l PFOA in j Blood Data
C ham bers W orks, G en eral PFOA in
Experim ental
Blood Data
Station , Finishes
Plants, Spruance,
W ashington W orks,
W ilm ington
I
0 3 5 - 0 1 8 ... [1 9 8 1 0 5 1 4
[Table: C -8 L e ve i L o c a tio n s O ther than W ashington W orks
no further inform ation id e n tifie d
C-8
ino further inform ation id e n tifie d
10 3 5 -0 1 9
[19820825
[Correspondence from [T im o th y P. P a sto o r to J. G. [Loschiavo entitled ["Am m onium
jno further [inform ation [id e n tifie d
[P e rflu o ro o cta n o a te ( C - 8) in
[Hum an Blood"
10 3 5 -0 2 0 " ' [un d ate d
[Additional Inform ation for [ S u p e rv is io n
[no further inform ation
IHU
!0 3 5 -0 2 2
IM l #
[undated :un da te d 980827
[ id e n tifie d
[Table: Em ployee Blood
ino further
[Data (1979, 1981, 1999)
;
[inform ation i identified
Table: E m ployee Blood
[no further
[Data (1979, 1981, 1999) [inform ation
id e n tifie d
[Table: A na lytical Results: no fu rth e r
[FC -143 in Blood P olym e r [inform ation
[Products - C ham bers W orks [identified
10 3 5 -0 2 3 [1 9 9 9 0 9 2 3
I3 if/ 7 !
[Memo from Robin C.
[no further
Leonard to Barbara Dawson [inform ation
e n title d " C -8 S u rv e illa n c e " id e n tifie d
i035-024
I
120001019* IE -m ail from B a rb a ra J. [Dawson to m u ltip le people entitled "C 8 Follow -up Medical Surveillance"
ino further inform ation id e n tifie d
jAm m onium [P e rflu o ro o c ta n o a te j
jn o fu rth e r jinform ation [identified
[F lu o rin e
[F lu o rin e
[ C -8................................
Am m onium P e rflu o ro o c ta n o a te
[no further [inform ation [identified [no further [inform ation jid e n tifie d [no further [inform ation [identified [no further [inform ation [id e n tifie d
C -8 no fu rth e r inform ation id e n tifie d
C -8 Ino fu rth e r [inform ation Iid e n tifie d
'[3 8 2 5 - 2 6 - ............ T a b le
jn o fu rth e r [inform ation jid e n tifie d
jno further [inform ation jid e n tifie d
[3 8 2 5 - 2 6 - 1 ............. C o rre sp o n d e n c e jn o fu rth e r [inform ation jid e n tifie d
jno further [inform ation [ id e n tifie d
jC irc le v iiie , [Chestnut Run, [Fairfield, Haskell, [Spruance, Toledo, [W ilm ington
[G e n e ra l P FO A in [Blood Data
jno further [inform ation jid e n tifie d
[G e n e ra i P FO A in [Blood Data
[7 7 8 2 - 4 1 - 4 ...... [C o rre sp o n d e n c e [no fu rth e r
[inform ation
[7782-41-4
[Table
[ id e n tifie d jno further
jinform ation
; ....................... ..... ..........
13825-26-1
[Table
[identified [no further
inform ation
i .................... [3825-26-1
[fab le
identified [no further
[inform ation
[ id e n tifie d
3 8 2 5 - 2 6 - .......
[M em oran du m
no fu rth e r inform ation id e n tifie d
3 8 2 5 - 2 6 - 1 ........ [E m a ii
no further inform ation id e n tifie d
[no further i inform ation [identified jno further [inform ation i identified no further inform ation id e n tifie d no further inform ation identified
no further inform ation id e n tifie d
no further inform ation identified
[C h a m b e rs W o rk s [G e n e ra l P FO A in [Blood Data
1C h a m b e rs W o rks, [G e n e ra l P FO A in
[W ilm ington
!B lood D ata
iC h a m b e r s W o rks, G e n e ra l PFO A in
W ilm ington
Blood Data
[Cham bers W orks
Data
[Cham bers W orks
PFOA in Blood Data
[Cham bers W orks
PFOA in Blood Data
Com pany Sanitized - Contains No TSCA CBI
Volume 35 Blood Monitoring
000009
Page 3 of 8
INDEX I _ ; n u m b e r ! DATE j t it l e / d e s c r ip t io n
10 3 5 -0 2 5
I
120001019 I
[E-M ail from B a rb a ra J. jDaw son to m u ltip le people [entitled "C8 M edical [Surveillance - Draft Letter jto Participants"
REPORT NUMBER
Ino further j inform ation id e n tifie d
i 0 3 5 - 0 2 6 ... [20010119*
IMM I
j.:E-M ail fro m B a rb a ra
Trio fu rth e r
;D aw son to R o b in C. Leon ard jin fo rm a tio n
entitled "N M S Results"
[id e n tifie d
10 3 5 -0 2 7
5 ^ 3
20041120 Sum m aries of C ham bers [W orks PFOA in Blood
[0 3 5 -0 2 8 [un dated
13^f|
[Proposal for Feasibility [Assessm ent entitled " [Estim ating Exposure, [Biopersistence, and [Potential Liver Effects from [W orkplace E xp o su res to [O rganofluorines: A [determ ination o f the :fe a s ib ility o f a p p ro p ria te analyses o f historical surveillance data",
ino further [inform ation [identified no further inform ation id e n tifie d
j SUBJECT MATERIAL I TRADENAME or CODE
C-8 jno further jinform ation id e n tifie d
j CAS REGISTRY j NUMBER
DOCUMENT TYPE
3 8 2 5 - 2 6 - ............. E m a il
EPA DOCKET
"B a te s" NUMBER
[no further j inform ation id e n tifie d
jno further jinform ation [id e n tifie d
SITE
CATEGORY -!
jCham bers Works
PFOA in Blood Data
C-8 no further inform ation id e n tifie d
[Perfiuorooctanoic Acid [no further [inform ation
j...........................................id e n tifie d C-8 no further
inform ation identified
i 3 8 2 5 -2 6 -1
Em ail
335-67-1 3825-26-1
T a b le Proposal
no further inform ation identified
no further inform ation id e n tifie d no further inform ation id e n tifie d
no further inform ation id e n tifie d
no further inform ation id e n tifie d no further inform ation id e n tifie d
[C h am bers W orks [PFOA in Blood [Data
[C h am be rs W orks [PFOA in Blood [Data
[C h am bers W orks [PFOA in Blood [D ata
[ [
10 3 5 -0 2 9 0 3 5 -0 3 0
[19811020 [Table: D uPont de N em ours jno further j(N ederland) B.V. D ordrecht [inform ation .W orks..................................... j id e n tifie d
i 19970200* [Two pages extracted from C-jno further [8 PACE Team M eeting N otes [inform ation jw ith blood da ta from th e Iid entified [Dordrecht W orks
10 3 5 -0 3 1 [un d ate d 15427 j 10 3 5 - 0 3 2 ... [ 9 8 2 0 *
\3 ^\
[0 3 5 - 0 3 3 ... [20031215*
!3^ |
j C -8 in B loed M o n ito rin g [Results in FLPR D ord recht
[Memo from S. R. Laas to J. jD. De Lau ren tis, M.D. [entitled "A n a ly sis of Blood [Sam ples for IP.?fii.y o ro o cta no at e " [Exposure Assessm ent Protocol entitled "Exposure [Assessm ent of Measured [Serum Perfluorinated [O ctanoic Acid A nio n in the Manufacture of Am m onium [Perfluorooctanoate (APFO) [at F a y e tte v ille , N C "
[no further [inform ation [identified [no fu rth e r inform ation id e n tifie d
15076
iC -8 C-8
[no fu rth e r [inform ation id e n tifie d no further inform ation id e n tifie d
[C -8 ............................ [P e rflu o ro o c ta n o a te
[no further [inform ation id e n tifie d [no further [inform ation j id e n tifie d
A m m onium P e rflu o ro o c ta n o a te
jno further jinform ation [identified
3 8 2 5 - 2 6 - ............ T a b le ................
.......
13825-26-1
Graph
[no further [inform ation j identified [no further jinform ation [identified
[no further jinform ation j id e n tifie d [no further [inform ation [ id e n tifie d
1*3825-26-1............. R e p o rt
[3825-26-
M em orandum
[no further [inform ation [id e n tifie d [no further jinform ation [identified
[no further [inform ation
[no further inform ation [ id e n tifie d
3 8 2 5 - 2 6 - ............. S tu d y
[no further [inform ation [identified
;no further [inform ation [id e n tifie d
D ord re ch t W orks [PFOA in Blood [Data
D o rd re ch t W orks jPFO A in Blood [Data
D ord recht W orks [PFOA in Blood [Data
Experim ental j Station j
[Data
j F a y e tte v ille W orks jPFO A in Blood [ [Data
=0 3 5 -0 3 4
\jjf30
20041119 [Sum m aries of Fayetteville [W orks PFOA in Blood D ata
[no fu rth e r inform ation id e n tifie d
Perfiuorooctanoic Acid jno further [inform ation
.......................................... Lidentified
335-67-1
[Table
Com pany Sanitized - Contains No TSCA CBI
Volume 35 Blood Monitoring
no further inform ation
[no further [inform ation [ id e n tifie d
[F a y e tte v ille W o rk s fp FO A in B lo o d ....... !
j
jD a ta
j
i j
OOOOIO
Page 4 of 8
i INDEX i i NUMBER j
DATE
| 35-Q35 1 9 8 0 0 2 2 5
IM3
T IT LE /D E SC R IP T IO N
REPORT NUMBER
Tno[M em o fro m E. R. P u rch a s e
f u r t h e r ........
jto G. L. W a tts e n title d "F C - [in fo rm a tio n
1143 S u rfa c ta n t"
[ id e n tifie d
mt
10 3 5 -0 3 7
0 3 5 -0 3 8
undated Table: Table II G C P re cisio n jn o further
j inform ation
....................I ................................................... id e n tifie d 1 9 7 9 1 0 1 0 [Table: O rg a n ic F lu o rid e s in [no f u r t h e r ..........
iBlood Sam ples
inform ation
.....................i ...................................................iw s t!fj d 1 9 7 9 1 0 1 6 [H a n d -w ritte n ta b le e n title d jn o f u r t h e r .........
"O rganic Fluo rid es in Blood lin fo rm a tio n
[Sam ples C o m plete R esu lts" identified
j SUBJECT MATERIAL 1 TRADENAME or CODE
Am m onium ;P e rflu o ro o c ta n o a te
[F C -1 4 3
| CAS REGISTRY ! DOCUMENT
\1 N U M B E R
TYPE
13825-26-1
Mem orandum
j*........................... j EPA DOCKET 1
j
"B a te s" NUMBER
jno further [inform ation [identified
[inform ation [identified
[Am m onium i Perfluorooctanoate
[F C -1 4 3
i.........................................
O rganic Fluorides
[no further
inform ation
......................................... ;id e n tifie d
:O rganic Fluorides
|no further
inform ation
id e n tifie d
[3 8 2 5 - 2 6 - 1 ............ [Table
jno further inform ation id e n tifie d [no further [inform ation id e n tifie d
fa b le Table
Ino further inform ation id e n tifie d no further inform ation id e n tifie d no further inform ation id e n tifie d
[SPR000321
inform ation no further inform ation identified
SITE [Spruance
j CATEGORY .
jp FO A in Blood [Data
[Spruance
PFOA in Blood Data
W ashing to n W orks PFOA in Blood Data
W ashing ton W orks PFO A in Blood Data
10 3 5 -0 3 9
198 1 0 5 1 4 [Table: C -8 Level - C u rre n t jno fu rth e r
[W ashington W orks Fem ale [inform ation
[Em ployees
[id e n tifie d
[0 3 5 -0 4 0 [1 9 8 1 1 2 0 1
j 3H-3G j
[ 3 5 - 0 4 1 ... 9 8 2 0 2 2
\itf1\
Table: C -8 Blood Le ve ls in in o fu rth e r
Fem ales Transferred O ut o f lin form ation
L i? I9!........................................ ] W entfe d M em o from j . F. D o u g h ty to Ino fu rth e r
;R. D. Ing alls entitled "W o rk info rm atio n
iH istories o f Fem ales"
[identified
I 3 5 - 0 4 2 ... 9 8 2 0 7 1 4
j
iM em o from J. G. Loschiavo Ino fu rth er
to R. J. B urg e r entitled
linform ation
"Trends in Blood C -8 Le ve ls [identified
for V ario us Teflon
Em ployee G roups"
[0 3 5 -0 4 3 [ 1 9 8 2 0 7 2 ?
j34-3^
[Memo from j. G. Loschiavo ito R. J. Z ip fe l entitled "Retention o f A m m onium P e rflu o ro o c ta n o a te (C -8 ) In Blood of Teflon Em ployees"
no further inform ation id e n tifie d
C - 8 .................................. [no fu rth e r linform ation id e n tifie d
C - 8 .................................. no fu rth e r
inform ation
[Fluorine
identified no further
inform ation
id e n tifie d
TC - 8 ................................... no fu rth e r inform ation id e n tifie d
[Am m onium [P e rflu o ro o c ta n o a te
[no fu rth e r'" [inform ation id e n tifie d
[ 3 8 2 5 -2 6 -1 ............. T a b le .................... no fu rth e r inform ation id e n tifie d
7 3 8 2 5 - 2 6 - 1 ............. T a b le
j [7782-41-4
T a b le
no further inform ation id e n tifie d no further inform ation id e n tifie d
[ 3 8 2 5 -2 6 -1 ............. M e m o ra n d u m
no further inform ation identified
no further inform ation id e n tifie d
no further inform ation identified no further inform ation identified
no further inform ation id e n tifie d
[W ashington W orks PFOA in Blood Data
[W a sh in g to n W o rk s [PFO A in B lo o d ...... ! [Data
[W a sh in g to n W o rks [PFO A in B lo o d ...... ; [Data
[W a sh in g to n W o rks [PFO A in B lo o d ...... Data
3825-26-1
[M em orandum [
[no fu rth e r ......[rio fu rth e r
[inform ation [inform ation
[id e n tifie d
[id e n tifie d
W a sh in g to n W o rks [PFO A in B lo o d ...... [Data
[0 3 5 -0 4 4 [1 9 8 2 0 9 2 8 134^ 1
[Memo from J. G. Lochiavo tojno further
|R. J. Z ip fe l e n title d
[inform ation
l'A m m oniu m
id e n tifie d
Perfluorooctanoate in Blood [
of Teflon E m p lo y ee s"
I
Am m onium [P e rflu o ro o c ta n o a te
[no further [inform ation [identified
[0 3 5 -0 4 5
\m
19830811
[M em o fro m i G. L o s c h ia v o '*7no f u r t h e r ..........
[to T. M. Kem p e ntitled
[inform ation
"U pdate on the C -8 Blood |identified
[Sam pling Program "
C - 8 ...............................
1no fu rth e r [inform ation [ id e n tifie d
3 8 2 5 - 2 6 - ....... [M e m o ra n d u m
no further inform ation id e n tifie d
[no further linform ation [ id e n tifie d
..... [ 3 8 2 5 - 2 6 - ....... [M e m o ra n d u m
no further inform ation identified
[no further inform ation [identified
iW a sh in g to n W orks :PFOA in Blood Data
IW ashington W orks PFOA in Blood Data
[Q35-Q46 [19831010 H and-w ritten table w ith no
j3 4 ^ j
j title
no further inform ation id e n tifie d
C-8
no further inform ation
identified
[ 3 8 2 5 - 2 6 - ............. [T a b le '
no further
[no further
inform ation [inform ation
jd e n tifie d ........... [.identified
W a shing to n W orks PFOA in Blood Data
Com pany Sanitized - Contains No TSCA CBI
Volum e 35 Blood M onitoring
OOOOll
Page 5 of 8
INDEX j NUMBER i DATE j TITLE/DESCRIPTION
REPORT NUMBER
035-047 119831019
..MiI
0 3 5 - 0 4 8 ....F 9 8 3 0 2 7
[Tables w ith C -8 Blood jSam ple Results by Job
ino further i inform ation
id e n tifie d
[Mem o from J. G. Loschiavo [no fu rth er
jto J. W. Raines entitled
[inform ation
["W ashington W orks Blood C -[identified [8 Levels fo r Non-
j Fluoropolym ers D ivision
i Em ployees"
! SUBJECT MATERIAL [ TRADENAME or j CAS RESISTRY ! DOCUMENT
CODE
NUMBER
TYPE
i C -8
[ [C -8
I
no further [inform ation [identified jno further inform ation identified
[3825-26-1
. i. [3825-26-1
[Table [M em oran du m
j era d o c k et;
m - ,, r
[no fu rth e r jinform ation identified jno further inform ation id e n tifie d
jno further jinform ation identified jno further inform ation identified
... 7.....*...........................
SITE
|
CATEGORY .
jW a shing to n W orks jPFO A in Blood Data
j W ashington W orks PFOA in Blood jD a ta
=0 3 5 -0 4 9 10 3 5 -0 5 0
119840611 i19840614
jT a b le e n title d "T a b le 1: jTeflon Fine jPow der/D ispersion [O perators C -8 Blood Sam pl j Results" hand-dated 6/11/84 jM em o from j. G. Loschiavo jto T. M. Kem p entitled "Update on th e C -8 Blood Sam pling Program "
[no further [inform ation [ id e n tifie d
[no further [inform ation [identified
[C-8 [
fc-8
no further inform ation identified
no further inform ation id e n tifie d
'[ 3 8 2 5 - 2 6 - 1 ........... [T a b le .................
no further inform ation identified
[no further jinform ation [id e n tifie d
jW a shing to n W orks jPFO A in Blood jD a ta
3 8 2 5 - 2 6 - 1 ........... [M e m o ra n d u m
no further inform ation id e n tifie d
jno further inform ation [ id e n tifie d
jW ashing to n W orks PFOA in Blood Data
i j
j 03 5 -0 5 1 j 1 9 8 7 0 6 0 9 T able e n title d " C -8 T re n d in [no fu rth e r
IW 7 |
j Blood"
[inform ation identified
j 3 5 - 0 5 2 ....[ 9 8 7 0 6 1 0 iT a b ie e n title d "W W C -8
[no further
\ w l . I.
j Blood A n a lyse s (NonQuorocarbon Exposure)"
[inform ation identified
j35 -0 5 3 =19870806 j H and-draw n graphs Blood C [no fu rth er
I j 8 Level C hange vs. Tim e [inform ation [identified
=0 3 5 - 0 5 4 ....[1 9 8 9 0 6 1 4 '' M em o from R. D. Lan y on to [no fu rth e r
[H. A. S m ith e t al e n title d "C [inform ation
;8 Blood D ata "
id e n tifie d
10 3 5 -0 5 5
119900319
jM e m o fro m H. A. S m ith to J.fn o fu rth e r
|G. Loschiavo et al entitled "Review o f W ashington
inform ation id e n tifie d
jW orks C-8 Data Personnel
Air M onitoring and Blood
Data"
[C-8 [
no further inform ation
[C-8
id e n tifie d no further
i jC-8
inform ation identified no further
inform ation [ identified [ c - 8 ................................... 1no fu rth e r
nform ation [ [ dentified
[C -8 .................................... no fu rth e r i nform ation [ [ dentified
'3 8 2 5 - 2 6 - 1 ........... jT a b le
.1 ...
j3 8 2 5 -2 6 -l
[3825-26-
: [3825-26-1
jT a b le ; [Graph
[M em oran du m
no further inform ation id e n tifie d no further inform ation identified no further inform ation identified no further nform ation d e n tifie d
3 8 2 5 - 2 6 - ............ M e m o ra n d u m
t no further nform ation d e n tifie d
jno further jinform ation [id e n tifie d [no further jinform ation i identified [no further jinform ation jid e n tifie d jno further jinform ation [ id e n tifie d
jno further inform ation [id e n tifie d
jW ashing to n W orks PFOA in Blood Data
[
jW ashington W orks PFO A in Blood Data
jW ashing to n W orks PFOA in Blood D ata
i j
jW a shing to n W orks PFOA in Blood Data
jW a shing to n W orks PFOA in Blood Data
0 3 5 -0 5 6 1 9 900400 R e p o rt e n title d " R e v ie w o f jn o fu rth e r
jW ashington W orks C-8 Data jinform ation
I5 ^
Personnel A ir M onitoring
j .........
land Blood"
\n\i1 9 9 2 0 1 0 2 ? f a ble s .......
IwiI 35- 58... [ 994 jT able e ntitled 1994 C -8 in Blood R e su lts"
j identified
no further inform ation identified jno further inform ation [ id e n tifie d
jC -8 jC-8
jno further [inform ation id e n tifie d
jno further [inform ation [identified [no further [inform ation [id e n tifie d
3 8 2 5 - 2 6 - 1 ............. R e p o rt
[no further [inform ation identified
[3825-26-1 3825-26-1
" T a b le ................... [no fu rth e r
inform ation
identified
T a b le
jno further
inform ation
identified
[no further inform ation id e n tifie d
no further inform ation identified no further inform ation id e n tifie d
[W ashington W orks j PFOA in Blood Data
[
W a sh in g ton W o rks 3F a in B lood Data
W ashington W orks j ' FOA in Blood
i !
p . 11
Company Sanitized - Contains No TSCA CBI
Volum e 35 Blood M onitoring
000012
Page 6 of 8
j INDEX ; NUMBER
DATE
T IT LE/D E SC R IPT IO N
REPORT NUMBER
10 3 5 - 0 5 9
3 ^
j 19970617 |
[E-m ail from A nthony j.
Ino further
jP la y tis to Y o u n g e r L. P o w e r [in fo rm a tio n
entitled "1 9 9 7 V oluntary C- [identified [8 Blood Te stin g "
SUBJECT M ATERIAL 1 TRADENAME or CODE
C-8 no further [inform ation [identified
I CAS REGISTRY i DOCUMENT
NUMBER
TYPE
j3825-26-1
:Em ail
| EPA DOCKET
"B a te s" NUMBER
[no further [inform ation [identified
no further inform ation id e n tifie d
SITE
CATEGORY .
[W ashington W orks PFOA in Blood Data
10 3 5 -0 6 0 "' 1 1 9 9 71103 [R ep o rt by A. j. P la ytis
Ino further
[entitled "R esu lts of the j 1995 Stu d y of C -8 Blood
inform ation i identified
....................i{r.?.y.?.!.w 035-061 " 120000802 [E-m ail from A n th o n y J.
Ino further
iP la ytis to Robbin Banerjee [inform ation
3^7 j j
jet all entitled "P re lim in a ry 8 Blood R esults for [W ashington W orks"
id e n tifie d
[C-8 C-8
[no further [inform ation [identified
[no further [inform ation [identified
; 38*25-2*6-
Report
T 3 8 2 5 - 2 6 - ............. E m a il
[no further [inform ation [identified
[no further inform ation [id e n tifie d
no further inform ation id e n tifie d
no further inform ation identified
W ashington W orks PFO A in Blood Data
[W ashington W orks PFOA in Blood Data
1035-062 [2 0 0 0 0 8 0 8
I34#
[Memo from Anthony j. [Playtis to G ary W. Jepson ^entitled "P e n s io n e r B lood
.j,................... D a ta "
1035-063... [2 0 0 0 1 1 1 7 [P re se n ta tio n e n title d
fn o f u r t h e r ........ [inform ation [id e n tifie d I Ino f u r t h e r ..........
[
I J 4 7? I
["W ashington W orks Blood [inform ation [Data S u m m a ry " by R. F. identified
.................. iP.ln.9.!l.9^..
j
jQ35-064 [2 0 0 4 1 1 2 0 [S u m m a rie s o f b lood d a ta by [no fu r t h e r .........
]} ^ 0
[year and spreadsheets [containing raw data
[inform ation |id e n tifie d
0 3 5 -0 6 5 ... [undated [Ta b le e n title d "W W A P FO 'm ' [no fu rth e r
j 5 ^ 1 [Blood, 1985 and 1984" i .................. 035-066'... [undated [T itle e n title d " H a lf Life
[inform ation [identified [no further
I \ Utj^ ........
j'035-067... [un dated
.j.... I35-68... [un dated
\ ^ 1..................
10 33 -0 60 ... [un dated
[Results from Pensioners" [inform ation
identified
[T a b le e n title d " W W A P FO in [no fu rth e r
[Blood, 1 9 8 9 -9 0 "
inform ation
[identified
[Table entitled "A verage for [no further
[Job"
[inform ation
id e n tifie d
[Series of tables, 10 pages [no further
[inform ation
10 35 -070....[ 9 8 7 0 3 2 4
jI
;
[Kinetics of Som ption and [Elim ination of Fluorinated [Su rfactan ts in Blood
[identified [JL-87-5
[Q35-71 [un d ate d
\H&7 I
i'0 3 5 - 0 7 2 ... 9 7 9 0 3 5
jj
[O rg a n ic F lu o ro c o m p o u n d s in ln o f u r t h e r ..........
j B lo o d
[inform ation
[................................................... [id e n tifie d
[L e tte r from S id n e y Peil to"p.'n o " f u r t h e r ..........
[G. G ilb y e n title d "C h a m b e rs [in fo rm a tio n
iW orks Fluorosurfactant ^Study"
[identified
[C-8
[no further inform ation [id e n tifie d
[3825-26-1
[Em ail
Ino further [inform ation [ id e n tifie d
Ino further [inform ation [identified
........[38*25-26-1............ [P re se n ta tio n
Ino further [inform ation [identified
[Perfluorooctanoic Acid [no further [inform ation :id e n tifie d
........ 3 3 5 - 6 7 - 1 .............. [ f a b le .................
Ino further [inform ation [id e n tifie d
[APFO
[APFO [APFO
j),alpha-fluoro-om egaI(2 -su lfo e th y l)-
[no further [inform ation
........[ 3 8 2 5 -2 6 - ............. [T a b le .................
id e n tifie d
[no further [inform ation
[3825-26-1
[Table
^Identified [no further inform ation
;
|3825-26-l
[Table
[id e n tifie d ______
no fu rth e r [inform ation
[3825-26-1
fa b le
i id e n tifie d _______
[no further [inform ation
i 3825-2*6-1
Table
|id e n tifie d jiC B lj
I8 0 0 -3 7 -3
Report
[no further [inform ation [identified Ino further [inform ation [identified Ino further [inform ation [identified [no further [inform ation [identified Ino further [inform ation [ id e n tifie d [no further [inform ation [identified
[O rg a n ic Fluorocom pounds
F lu o rin e
no further inform ation id e n tifie d no further inform ation id e n tifie d
Ino further inform ation id e n tifie d [7782-41-4
M em orandum Ino further [inform ation [id e n tifie d
Correspondence [no further [inform ation [ id e n tifie d
[inform ation [identified
Ino further [inform ation [identified
Ino further [inform ation [id e n tifie d
[inform ation [identified
[inform ation [identified Ino further [inform ation [id e n tifie d no further [inform ation 'id e n tifie d
inform ation id e n tifie d no further inform ation identified
id e n tifie d
id e n tifie d
[W ashington W o rks [PFOA in Blood [Data
[W ashington W o rks jPFO A in Blood [Data
[W ashington W orks [PFOA in Blood" [Data
[W ashington W o rks [PFOA in Blood [Data
[W ashington W o rks [PFOA in Blood [Data
[W a sh in g to n W o rks [PFO A in "B lo o d ... [Data
[W ashington W orks PFOA in Blood Data
[W ashington W orks PFOA in Blood Data
[no further inform ation id e n tifie d
[Teiom ers Blood Data General j
no further inform ation id e n tifie d
Cham bers W orks
iT e io m ers Blood [Data General
[Teiom ers Blood [Data
Com pany Sanitized - Contains No TSCA CBI
Volum e 35 Blood M onitoring
000013
Page 7 of 8
i INDEX
; NUMBER I
DATE
I TITLE/DESCRIPTION
j ;
REPORT NUMBER
035-073 119790518 {Chambers W orks
In o f u r t h e r .......
|$ W
[Fluorochem icals in Blood [inform ation 4 .................... S tu d y ......................................... id e n tifie d
10 3 5 -0 7 4 ""' 1 1 9 9 90305 j E -m a il from B a rb a ra 1.
jno further
Daw son to Carol S. Lyell {inform ation
\WiB
[entitled "1 9 7 8 -7 9 C ham bers [identified [W orks O rg a n ic F lu o rin e in [Blood M onitoring Program j
[ SUBJECT M ATERIAL { TRADENAME or CODE
{Fluorine F lu o rin e
[no further [inform ation [id e n tifie d [no further [inform ation [identified
j CAS REGISTRY NUMBER
DOCUMENT TYPE
{7782-41-4
[Study
17782-41-4
{E m a il
EPA DOCKET
"B a te s" NUMBER
[no further inform ation id e n tifie d no further inform ation id e n tifie d
[no further [inform ation [ id e n tifie d [no further [inform ation [id e n tifie d
SITE
CATEGORY
{Cham bers W orks [Telom ers Blood [Data
{Cham bers W orks [Telom ers Blood {Data
j 0 3 5 - 0 7 5 .... [2 0 0 0 0 3 2 1
hkV
[E -m a il from S u sa n S. M ile ti jn o f u r t h e r ........ jto G e ra ld L. K e n n e d y and { in fo rm a tio n [Stephen H. Korzeniow ski [identified [entitled "CW blood [m onitoring C -8 & total F" I
F lu o rin e
10 3 5 - 0 7 5 .... [2 0 0 0 0 3 2 1 [E -m a ii fro m S u s a n S. M ile ti In o f u r t h e r ...............C -8 ........
[to G erald L. K e n n e d y and [in fo rm atio n
{
! yn-i i
[Stephen H. Korzeniow ski [entitled "CW blood
[id e n tifie d
[ [m onitoring C -8 & total F"
10 3 5 - 0 7 6 ....
